Global Microfluidic Devices Sales Market Report 2021

Microfluidics is an evolving scientific field with numerous analytical applications and commercial potential. It has several applications in the field of medicine, cell biology research and protein crystallization. Thus, microfluidic technology is an important tool to reduce side effects and improve the efficacy of treatments.
North America has the largest share in the global microfluidic device market. In-vitro diagnostics is the largest industry, and clinical and veterinary diagnostics is the largest application of microfluidic device market. In terms of growth, Asia is the fastest growing region, medical devices are the fastest growing industry and point of care testing is the fastest growing application of microfluidic devices.

Market Analysis and Insights: Global Microfluidic Devices Market
The global Microfluidic Devices market was valued at US$ 5251.4 in 2020 and will reach US$ 10930 million by the end of 2027, growing at a CAGR of 13.0% during 2022-2027.

Global Microfluidic Devices Scope and Market Size
The global Microfluidic Devices market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Microfluidic Devices market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.

Segment by Type
Polymer
Glass
Silicon
Other

Segment by Application
In-vitro Diagnostics (IVD)
Pharmaceuticals and Medical Devices
Other

The Microfluidic Devices market is analysed and market size information is provided by regions (countries). Segment by Application, the Microfluidic Devices market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions.

By Company
Roche
Abbott
Fluidigm Corporation
Johnson & Johnson
Siemens Healthcare
Agilent
Bio-Rad Laboratories